Resource Library
Showing 1 to 10 of 321 results
Image
Beyond active surveillance (the ‘watch and wait approach’) there are several CLL treatments to consider. Each treatment has different features and side effects. It is important to be comfortable with the CLL treatment you choose.
Image
Diffuse Large B-Cell Lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma (NHL). DLBCL is fast-growing (aggressive) but treatable. It most often appears in older adults but can appear at any age.
Image
Cutaneous T-cell lymphoma (CTCL) is a slow-growing (indolent) subtype of non-Hodgkin lymphoma (NHL). CTCL is rare, representing 4% of NHL cases. It starts in white blood cells (lymphocytes) that reside in the skin, called T-cells.
Image
Mantle cell lymphoma (MCL) is an aggressive subtype of non-Hodgkin lymphoma. It is a blood cancer of the B-lymphocytes (type of white blood cell that fights infections) found in the bone marrow. Learn more about MCL in this animated video.
Image
In partnership with Cell Therapy Transplant Canada (CTTC), The Leukemia & Lymphoma Society of Canada (LLSC) is pleased to provide this special, 90-minute webcast on the latest innovations in blood cancer treatment in Canada.
Image
Myelodysplastic syndromes are a group of cancers of the blood and bone marrow. With an MDS, your bone marrow – the soft, spongy material inside your bones – does not produce enough healthy blood cells.
Image
David Johnson, of BC, first diagnosed with the disease in 2012 in his early 50s, has experienced 2 relapses, 2 stem cell transplants, and participated in a clinical trial for CAR T-cell therapy. Dr. Anthony Reiman, medical oncologist in NB, talks about advances in MM treatment.
Image
This fact sheet provides an overview of GvHD for healthcare professionals. It reviews presenting symptoms, treatment options and side effects to effectively support your patients.
Image
AML is one of four main types of leukemia. It progresses quickly if untreated. It features cancerous blood cells, often called “blasts.” AML typically affects adults over the age of 65 and is slightly more common in men.
Image
AITL is a rare, fast-growing (aggressive) T-cell subtype of non-Hodgkin lymphoma (NHL) and a common subtype of peripheral T-cell lymphoma (PTCL). AITL typically affects adults over 50.